Semaglutide 10mg

Mid-Range GLP-1 Agonist for Versatile Metabolic Research

Semaglutide 10mg is a versatile mid-range long-acting glucagon-like peptide-1 (GLP-1) receptor agonist designed for flexible metabolic research. This 10mg supply provides researchers with an ideal balance between affordability and sufficient material for comprehensive studies in glucose regulation, weight management, and GLP-1 receptor mechanisms.

Why Researchers Choose Semaglutide 10mg:

• Versatile Mid-Range Supply: 10mg provides optimal flexibility for various research protocols and experimental designs
• Budget-Conscious Choice: Excellent value for laboratories seeking quality without overcommitting to larger quantities
• Well-Established Mechanism: Extensively studied GLP-1 agonist with decades of research documentation
• Long-Acting Profile: Extended half-life enables once-weekly dosing in research models
• Multiple Experiments: Sufficient quantity for several experimental runs and comparative studies
• Research-Grade Purity: Pharmaceutical-quality peptide (≥98%) for reliable outcomes
• Proven Efficacy: Clinically validated with robust weight loss and glycemic control data
• Extensive Literature: Thousands of published studies provide research foundation

Ideal Research Applications:

Perfect for laboratories conducting GLP-1 receptor research with moderate scope, comparative peptide studies, and multi-phase investigations. Semaglutide 10mg is particularly valuable for researchers who:

• Need flexibility to explore multiple research directions
• Are investigating GLP-1 receptor mechanisms and signaling pathways
• Want to use semaglutide as a benchmark for comparing novel peptides
• Require sufficient material for replicate experiments
• Are balancing research ambitions with budget considerations
• Need a reliable supply for ongoing research without excess inventory
• Are conducting dose-response studies and pharmacokinetic investigations
• Want to understand long-acting GLP-1 agonist mechanisms

Key Research Areas:

• GLP-1 receptor activation and signaling pathways
• Body weight regulation and appetite suppression mechanisms
• Glucose-dependent insulin secretion and glycemic control
• Satiety signaling and food intake regulation
• Gastric emptying and gastrointestinal motility
• Beta-cell function and pancreatic health preservation
• Cardiovascular benefits and cardioprotective mechanisms
• Neuroprotection and central nervous system effects
• Long-acting peptide pharmacokinetics and stability
• Comparative studies with dual agonists (e.g., tirzepatide)

Technical Specifications:

• Quantity: 10mg (versatile research supply)
• Type: Long-acting GLP-1 receptor agonist
• Structure: 31 amino acid peptide analog
• Form: Lyophilized powder for reconstitution
• Purity: ≥98% (HPLC verified)
• Molecular Weight: ~4113 Da
• Half-Life: Extended (suitable for once-weekly dosing in models)
• Storage: Store at 2-8°C before reconstitution; -20°C after reconstitution
• Solubility: Reconstitute with bacteriostatic water
• Stability: Enhanced stability with fatty acid modification

Research Advantages:

Semaglutide represents a highly successful GLP-1 receptor agonist with proven efficacy in both research and clinical settings. The 10mg supply provides researchers with a versatile quantity that supports diverse research objectives while maintaining cost-effectiveness.

GLP-1 Receptor Mechanism: Semaglutide activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite through central and peripheral mechanisms. This well-characterized pathway has made GLP-1 agonists a cornerstone of metabolic research.

Clinical Validation: Semaglutide has demonstrated impressive efficacy in clinical trials, achieving 15-17% body weight reduction and superior glycemic control. This robust clinical data provides researchers with a validated tool for understanding metabolic mechanisms and evaluating novel interventions.

Long-Acting Profile: Semaglutide's extended half-life (approximately 1 week) is achieved through albumin binding via a fatty acid side chain. This long-acting profile makes it ideal for studying sustained GLP-1 receptor activation and chronic metabolic adaptations.

Optimal for Multi-Phase Research: The 10mg quantity is ideal for researchers conducting multi-phase studies, allowing for initial experiments, protocol refinement, and validation studies without running short or having excessive unused material.

Comparative Research Value: This quantity is perfect for side-by-side comparisons with other metabolic peptides like tirzepatide or liraglutide, enabling researchers to understand semaglutide's mechanisms and compare efficacy profiles.

Research Flexibility: With 10mg, researchers can explore multiple dosing regimens, test various experimental conditions, conduct time-course studies, and maintain consistency across research phases while staying within budget.

Extensive Research Foundation: With thousands of published studies, semaglutide offers researchers a wealth of background data, validated protocols, and established methodologies. This extensive literature accelerates research planning and provides context for novel findings.

Important Disclaimer: This product is sold exclusively for research and laboratory purposes. Not intended for human consumption, therapeutic use, weight loss applications, or veterinary use. For in vitro and animal research only.

*Price per vial.
*This product is in powder form and is not reconstituted.
*For research purposes only.
*Tested at 99% purity.
*Free shipping.
*All sales final.